Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Metabolic disorders
Biotech
Rallybio revs up antibody discovery activities in AbCellera pact
The partners will co-develop up to five rare disease therapeutic targets in a risk-sharing pact, starting with a metabolic disease program.
Nick Paul Taylor
Dec 1, 2022 9:30am
OrsoBio emerges with frenzy of metabolic programs
Nov 2, 2022 10:20am
Lilly, Nimbus ink $496M biobucks deal
Oct 11, 2022 11:39am
Merck nails phase 3 sotatercept win a year after acquiring it
Oct 10, 2022 6:45am
Viking relaunches longship for metabolic disorder study
Jul 19, 2022 10:40am
New discovery links nicotine with obesity-fighting ‘beige’ fat
May 21, 2018 11:00am
